INVO Fertility (IVF) Return on Capital Employed Growth (5y) (2017 - 2026)
INVO Fertility (IVF) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.51 Mn | -3.39 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,909.00 |
| Sep 30, 2025 | 380,621.00 |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | -59,790.00 |
| Dec 31, 2024 | 11,060.00 |
| Sep 30, 2024 | 26,781.00 |
| Jun 30, 2024 | 35,803.00 |
| Mar 31, 2024 | -16,009.00 |
| Dec 31, 2023 | -16,855.00 |
| Sep 30, 2023 | -18,035.00 |
| Jun 30, 2023 | 40,809.00 |
| Mar 31, 2023 | 35,489.00 |
| Dec 31, 2022 | -164,898.00 |
| Sep 30, 2022 | -22,410.00 |
| Jun 30, 2022 | -13,943.00 |
| Mar 31, 2022 | -12,544.00 |
| Dec 31, 2021 | -11,529.00 |
| Sep 30, 2021 | -16,414.00 |
| Jun 30, 2021 | -12,802.00 |
| Mar 31, 2021 | -8,161.00 |